Australian owned and operated construction company Hansen Yuncken, has been appointed as Contractor in the delivery of the Vaxxas Biomedical Facility.
Located at Northshore, Brisbane, the facility will enable continued research and development as well as the manufacture of its world-leading, needle-free vaccine technology.
Due for completion by Q4, 2022, Vaxxas will be repurposing 4,200m2 of warehouse space previously used for airport parking. The existing building, positioned close to the future Brisbane 2032 Olympics Games Village, will be re-clad, refurbished and fitted out specifically for Vaxxas to accommodate ISO standard clean rooms, PC2 and BC2 certified laboratories, engineering and production spaces, and corporate offices.
Greg Baumann, QLD State Manager at Hansen Yuncken said, "We are delighted to be taking on such a pivotal role for Economic Development Queensland and Vaxxas, and are committed to delivering real outcomes to the highest standards"
"We bring extensive expertise in building laboratory facilities including careful planning and innovative thinking, using BIM technology to map base building elements and manage complex services installations to the project. We look forward to creating a world-class facility that will be home to a national-first needle-free vaccine manufacturing facility."
Acting across a host of key stakeholders for the project, Hansen Yuncken will be responsible for managing the procurement, coordination, and supervision of a range of qualified, reputable local industry specialists.
Deputy Premier, Steven Miles, said, "Hansen Yuncken was awarded the contract to refurbish an existing warehouse here at Northshore, which will create more than 80 construction jobs".
Vaxxas' Chief Operations and Development Officer Angus Forster said "We are pleased to be able to continue our work here in Brisbane and commend the Queensland Government for its investment in building Australia's local manufacturing capacity and job prospects".
The Vaxxas Biomedical Facility is a significant addition to Hansen Yuncken's strong portfolio of laboratory and Government projects.
